Metabotropic Glutamate Receptors Scientific Review
Request* your copy today
The Metabotropic Glutamate Receptors Scientific Review is part of the range of scientific reviews and bulletins produced by Tocris and written by leading experts summarizing the most recent developments in research and available products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Francine C Acher, Université René Descartes-Paris V
Review excerpt: "Glutamate has been shown to be involved in many neuropathologies, such as anxiety, pain, ischemia, Parkinson's disease, epilepsy and schizophrenia. Thus, because of their modulating properties, mGlu receptors are recognized as promising therapeutic targets. It is expected that drugs acting at mGlu receptors will regulate the glutamatergic system without affecting normal synaptic transmission."